Sohal D - Search Results

1

Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?

Turner KM, Delman AM, Vaysburg DM, Kharofa JR, Smith MT, Choe KA, Olowokure O, Sohal D, Wilson GC, Ahmad SA, Patel SH. Turner KM, et al. Among authors: sohal d. Ann Surg Oncol. 2022 Jun;29(6):3463-3472. doi: 10.1245/s10434-022-11363-0. Epub 2022 Feb 9. Ann Surg Oncol. 2022. PMID: 35141802

2

Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.

Moghanaki D, Mick R, Furth EE, Sohal D, Salmon PM, Behbahani A, Morgans AK, Miller SM, Giantonio BJ, Whittington RW, Haller DG, Rosato EF, Plastaras JP. Moghanaki D, et al. Among authors: sohal d. JOP. 2011 Sep 9;12(5):438-44. JOP. 2011. PMID: 21904068 Free article.

3

Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy.

Sohal DP, Walsh RM, Ramanathan RK, Khorana AA. Sohal DP, et al. J Natl Cancer Inst. 2014 Mar;106(3):dju011. doi: 10.1093/jnci/dju011. Epub 2014 Feb 22. J Natl Cancer Inst. 2014. PMID: 24563516 Review.

4

Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.

Sohal DP, Shrotriya S, Glass KT, Pelley RJ, McNamara MJ, Estfan B, Shapiro M, Wey J, Chalikonda S, Morris-Stiff G, Walsh RM, Khorana AA. Sohal DP, et al. Cancer. 2015 Jun 1;121(11):1779-84. doi: 10.1002/cncr.29298. Epub 2015 Feb 11. Cancer. 2015. PMID: 25676016 Free article.

5

Pancreatic Adenocarcinoma: Improving Prevention and Survivorship.

Sohal DPS, Willingham FF, Falconi M, Raphael KL, Crippa S. Sohal DPS, et al. Am Soc Clin Oncol Educ Book. 2017;37:301-310. doi: 10.1200/EDBK_175222. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561672 Free article. Review.

6

Adjuvant and neoadjuvant therapy for resectable pancreatic adenocarcinoma.

Sohal DPS. Sohal DPS. Chin Clin Oncol. 2017 Jun;6(3):26. doi: 10.21037/cco.2017.06.23. Chin Clin Oncol. 2017. PMID: 28705003 Free article.

7

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.

Dhir M, Malhotra GK, Sohal DPS, Hein NA, Smith LM, O'Reilly EM, Bahary N, Are C. Dhir M, et al. World J Surg Oncol. 2017 Oct 10;15(1):183. doi: 10.1186/s12957-017-1240-2. World J Surg Oncol. 2017. PMID: 29017581 Free PMC article. Review.

8

Do patients with pancreatic body or tail cancer benefit from adjuvant therapy?A cohort study.

Sohal DPS, Tullio K, Khorana AA. Sohal DPS, et al. Surg Oncol. 2018 Jun;27(2):245-250. doi: 10.1016/j.suronc.2018.05.008. Epub 2018 May 7. Surg Oncol. 2018. PMID: 29937178

9

Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database.

Mukhija D, Nagpal SJS, Sohal DPS. Mukhija D, et al. Among authors: sohal dps. Am J Clin Oncol. 2019 May;42(5):454-458. doi: 10.1097/COC.0000000000000544. Am J Clin Oncol. 2019. PMID: 30950860

10

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.

Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, Bellakbira S, Thach D, Rahib L, Madhavan S, Matrisian LM, Petricoin EF 3rd. Pishvaian MJ, et al. Among authors: sohal dps. Lancet Oncol. 2020 Apr;21(4):508-518. doi: 10.1016/S1470-2045(20)30074-7. Epub 2020 Mar 2. Lancet Oncol. 2020. PMID: 32135080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page